Global branded generics market value was USD 230.09 Billion in 2021. It is projected to grow at a compound annual rate (CAGR of 5.8%) between 2022 and 2031.

Growing Demand:

The primary driver of the global market is an increase in cardiovascular risk factors. Branded Generics Market growth also depends on the increasing incidence of cases of cancer. Global Branded Generics Market provides a comprehensive analysis of the market. The report includes a detailed analysis of key segments, market drivers, trends, restraints, competitive environment, and other factors that significantly impact the market.

Global demand for branded generics has increased dramatically in recent years. The pharmaceutical industry has many dynamic and intrinsic dynamics. These include manufacturing, licensing, and sales. Patenting is an extremely important principle in the pharmaceutical sector. Patented drugs give a particular entity legal rights in the pharmaceutical industry to sell the product. Patenting the products of pharma companies will allow them to avoid being affected by competitors.

To get a detailed analysis of other segments, Request for Sample@:

Driving Factors:

The restraining and driving factors will impact the branded generics industry. The increasing penetration of generics branded by a company and the government’s increased support for generics drive global market growth. The future trend for the market is likely to be encouraging healthcare professionals to use branded generics. But, generic medications have adverse side effects and poorer clinical outcomes that can hinder market growth for branded generics.

Restraining Factors:

“Lacking Awareness and Covid-19 Impact to Impede Market Progress”

The lack of information regarding generic drugs is one of the biggest bottlenecks in the pharmaceutical industry.

The brand name pharmaceutical advertising and marketing campaigns often overshadow generic drugs’ availability, which can replace more expensive medicines. Generic drugs are also known as branded drugs. Even though generic drugs have the same chemical composition as their counter-branded counterparts, Branded drugs are preferred by consumers, just like their counterparts.

Market Key Trends:

The US Food and Drug Administration is responsible for approvals of generic drugs.

The Federal Food Drugs and Cosmetics Act (FD&C Act) is another key entity that approves drugs. The recent relaxations granted by the authorities above will play an essential role in driving sales in the global branded generics marketplace. Other entities, research units, and organizations in other key regions made current investments in branded generics. This factor has opened up many growth opportunities in the global generics market. Without the need for patenting laws or regulations, vendors in global branded generics markets are expected to prosper.

These factors are expected to bring new revenue to the global branded generics industry. The hassles of patenting can be eliminated once a drug has become a generic product. The licensing fee is the only cost pharma companies must pay for selling generics. These costs and regulations can also differ depending on where they are located. Global branded generics markets offer strong growth potential. It is critical for pharma companies to be able to avoid unexpected costs. Global branded generics markets have become a magnet for new companies keen to venture into the pharmaceutical industry.

For Instant Purchase:

Industry Developments:

The Ministry of Health, Labour and Welfare approved Sawai Pharmaceutical Co. Ltd.’s Dutasteride Capsules on October 2020. ZAGALLO (Generic version) These pills can be taken to treat male pattern hair loss.

Key Market Players included in the report:

  • Mylan NV
  • Novartis AG
  • Eva Pharmaceutical Industries
  • Pfizer
  • Sun Pharmaceutical Industries
  • Aspen Pharmacare Holding
  • Abbott Laboratories
  • Valeant Pharmaceuticals International

Key Market Segments:

  • Oral
  • Parenteral
  • Topical


  • Oncology
  • Cardiovascular Diseases
  • Diabetes
  • Neurology
  • Gastrointestinal Diseases

Frequently Asked Questions (FAQ):

  • What is the future market size and growth rate for the Branded Generics Market?
  • What are the main driving factors for the Global Branded Generics Market?
  • Which are the top players in branded generics?
  • Which segments are included in the Branded Generics Market Report?
  • What is regional analysis?
  • How do I obtain a sample report/company profile for the Branded Generics Market?

Read Our Trending and Demanding Reports:


Market.US (Powered by Prudour Private Limited) specializes in in-depth market research and analysis and has been proving its mettle as a consulting and customized market research company, apart from being a much sought-after syndicated market research report providing firm.

Contact Details:

Global Business Development Team –

Address: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States

Phone: +1 718 618 4351 (International), Phone: +91 78878 22626 (Asia)